FOGAR, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.606
AS - Asia 10.544
EU - Europa 4.772
SA - Sud America 1.637
AF - Africa 1.538
OC - Oceania 151
Continente sconosciuto - Info sul continente non disponibili 150
Totale 37.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.559
SG - Singapore 3.416
CN - Cina 1.929
VN - Vietnam 1.415
HK - Hong Kong 1.064
BR - Brasile 995
IT - Italia 825
FI - Finlandia 475
PL - Polonia 472
BD - Bangladesh 466
FR - Francia 418
DE - Germania 404
SE - Svezia 301
IN - India 296
CA - Canada 245
GB - Regno Unito 220
UA - Ucraina 210
RU - Federazione Russa 190
IQ - Iraq 172
NL - Olanda 172
AR - Argentina 140
TR - Turchia 125
JP - Giappone 118
PK - Pakistan 116
MX - Messico 115
SA - Arabia Saudita 109
PH - Filippine 105
ID - Indonesia 91
ZA - Sudafrica 90
KR - Corea 84
CO - Colombia 81
EC - Ecuador 75
ES - Italia 72
VE - Venezuela 70
MY - Malesia 63
EG - Egitto 62
MA - Marocco 62
JM - Giamaica 61
IE - Irlanda 58
AT - Austria 57
PY - Paraguay 57
UZ - Uzbekistan 56
CR - Costa Rica 53
JO - Giordania 53
CL - Cile 52
GT - Guatemala 52
KZ - Kazakistan 52
LB - Libano 52
TH - Thailandia 52
TN - Tunisia 51
CI - Costa d'Avorio 50
KH - Cambogia 50
KE - Kenya 49
NP - Nepal 49
PA - Panama 49
AO - Angola 48
AE - Emirati Arabi Uniti 47
UG - Uganda 47
BJ - Benin 46
BO - Bolivia 46
BZ - Belize 46
HR - Croazia 46
BW - Botswana 45
AU - Australia 44
DZ - Algeria 44
MD - Moldavia 44
PE - Perù 44
TW - Taiwan 44
BY - Bielorussia 43
NI - Nicaragua 43
AZ - Azerbaigian 42
PR - Porto Rico 42
RO - Romania 42
GM - Gambi 41
PT - Portogallo 41
DO - Repubblica Dominicana 40
IR - Iran 40
ML - Mali 40
NO - Norvegia 40
PS - Palestinian Territory 40
TT - Trinidad e Tobago 40
CY - Cipro 39
KG - Kirghizistan 39
UY - Uruguay 39
AF - Afghanistan, Repubblica islamica di 38
CV - Capo Verde 38
CZ - Repubblica Ceca 38
EE - Estonia 38
ET - Etiopia 38
HU - Ungheria 38
YE - Yemen 38
AL - Albania 37
SN - Senegal 37
BE - Belgio 36
BG - Bulgaria 36
DJ - Gibuti 36
GF - Guiana Francese 36
LU - Lussemburgo 36
ME - Montenegro 36
AD - Andorra 35
Totale 35.608
Salva come PNG Salva come JPEG
Città #
Ashburn 2.156
Singapore 2.108
San Jose 1.985
Fairfield 1.088
Chandler 1.084
Woodbridge 1.058
Ann Arbor 959
Hong Kong 949
Houston 813
Jacksonville 773
Wilmington 542
Council Bluffs 447
Cambridge 437
Ho Chi Minh City 424
Bytom 390
Seattle 379
Los Angeles 366
Santa Clara 364
Beijing 363
Boardman 331
Hanoi 296
Princeton 264
Helsinki 230
Des Moines 210
Lauterbourg 207
Medford 198
New York 187
Nanjing 165
Dong Ket 109
Guangzhou 109
Roxbury 106
Dallas 103
San Diego 99
São Paulo 96
Milan 82
Da Nang 77
Rome 75
Buffalo 74
Chicago 72
Munich 69
Baghdad 67
Tokyo 58
Montreal 57
Orem 55
Haiphong 52
Nanchang 52
Amman 50
Padova 50
Tianjin 49
Abidjan 48
Dublin 48
Phnom Penh 48
Tashkent 48
Frankfurt am Main 47
Shenyang 47
Brooklyn 46
Kampala 46
Phoenix 46
Cotonou 44
London 44
Nairobi 44
Atlanta 43
Panama City 43
Warsaw 43
Johannesburg 41
Kingston 41
Managua 41
Shanghai 41
Denver 40
Jeddah 40
Bamako 39
Hebei 39
Luanda 39
Baku 38
San José 38
Addis Ababa 36
Dakar 36
Andorra la Vella 35
Changsha 35
Djibouti 35
Guayaquil 35
Riyadh 35
Bishkek 34
Montevideo 34
Vienna 34
Gaborone 33
Guatemala City 33
Harare 33
Kuala Lumpur 33
Lima 33
Lusaka 33
San Francisco 33
Toronto 33
Ulan Bator 33
Washington 33
Amsterdam 32
Antananarivo 32
Lahore 31
Praia 31
Redondo Beach 31
Totale 22.292
Salva come PNG Salva come JPEG
Nome #
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when? 372
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 354
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 348
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 332
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 330
Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis. 282
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 278
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 275
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 273
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 273
Cystic Fluid Total Proteins, Low-Density Lipoprotein Cholesterol, Lipid Metabolites, and Lymphocytes: Worrisome Biomarkers for Intraductal Papillary Mucinous Neoplasms 270
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 270
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 268
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 267
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation 267
Clinical utility of TPS, TPA and CA19-9 measurement in pancreatic cancer 265
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 263
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 261
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases. 258
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 257
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 257
Does serum CAR-3 play a role in pancreatic cancer diagnosis? 254
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 253
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 247
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 247
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 246
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 243
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications 240
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 239
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 235
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 235
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 234
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 231
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 227
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer. 224
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 223
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 222
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 221
Mucopolysaccharidosis type VII diagnosed from a peripheral blood smear 221
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 219
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 218
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 218
Modulazione termica dell'espressione della subunità  catalitica della tossina difterica e delle sue varianti CRM176 e CRM197 nella terapia genica del carcinoma del pancreas 218
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 216
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 215
In situ analysis of human menin in normal and neoplastic pancreatic tissues: Evidence for differential expression in exocrine and endocrine cells 215
Urinary phospholipase A2 excretion in chronic pancreatic diseases 211
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 210
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 210
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 210
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 204
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 204
Neonatal lymphocyte subpopulations analysis and maternal preterm premature rupture of membranes: A pilot study 204
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 203
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 203
Urinary kallikrein excretion in chronic pancreatic diseases. 203
T Cell Senescence by Extensive Phenotyping: An Emerging Feature of COVID-19 Severity 202
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 200
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 200
Effect of CagA status on the sensitivity of enzyme immunoassay in diagnosis Helicobacter pylori-infected children 199
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 197
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 196
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 196
Carcinogenetic potential of the WSR CagA region of Helicobacter pylori 195
Deoxyribonuclease I serum activity in pancreatic cancer. 194
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 194
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 194
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 191
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases. 191
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 191
V75Q576 IL-4Ra variant and IL-4 -588T allele favor cagA-positive Helicobacter pylori infections. 191
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 189
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 188
Beta-cell function in pancreatic adenocarcinoma. 188
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 188
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 184
Biological variability of lymphocyte subsets of human adults’ blood 184
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 183
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 183
Carcinogenetic potential of the WSR cagA region. 183
C-peptide pattern in patients with pancreatic cancer. 182
Synergistic effect of H. pylori infection and interleukin 12 polymorphisms for the development of gastric cancer 181
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 180
Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art. 180
Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases. 179
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 178
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 177
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 176
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 176
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 175
Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias. 174
SLC22A3 polymorphisms may influence overall patient survival-PANDORA study 174
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 173
CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein? 173
Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. 173
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 171
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 171
Analogues of vitamin E epitomised by alpha-tochopherol succinate (alpha-TOS) for pancreatic cancer treatment: in vitro results induce caution for in vivo applications 171
Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect 171
Circulating haematopoietic stem cells and long-term outcomes of COVID-19 168
Totale 21.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.122
article - articoli 45.163
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.330 0 0 0 82 60 161 50 143 89 31 185 529
2022/20232.282 438 260 26 267 387 363 8 122 275 26 81 29
2023/20241.088 42 136 111 75 68 176 71 97 27 56 101 128
2024/20254.716 22 234 259 207 652 100 186 291 465 176 877 1.247
2025/202617.374 668 1.468 2.220 2.091 1.776 720 2.546 1.639 1.836 1.136 739 535
2026/20272.837 774 850 878 335 0 0 0 0 0 0 0 0
Totale 37.398